Document is current
Any future updates will be listed below
-
Authors
Saeed, Sabrina
Chen, Tiffany X.
Huggins, Lenique
Leventhal, Jonathan
- License Information
-
More Information
Article History
Received: 7 April 2025
Revised: 7 April 2025
Accepted: 28 April 2025
First Online: 14 May 2025
Declarations
:
: Jonathan Leventhal received honoraria from Sanofi Regeneron and La Roche Posay for advisory boards; clinical trial research funding from OnQuality and Azitra, Inc; and royalties from UpToDate and Elsevier.
: Not applicable.
: Study determined to be IRB exempt.
: Jonathan Leventhal, jonathan.leventhal@yale.edu.
